CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- PREC14A Other PREC14A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $7.96 ($79,624)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Planned sale SVP, Finance & Corp Controller sold 3,000 shares at $7.86 ($23,588)
- 4 Planned sale CCO & EVP, Bus. Development sold 10,500 shares at $7.86 ($82,527)
- 4 Planned sale CFO & Treasurer sold 11,000 shares at $7.86 ($86,471)
- 4 Planned sale President and CEO sold 91,817 shares at an average $7.92 ($727,390)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 6 of 44 · 870 filings